Search Results - "DOLE, JO F"

A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes by RASKIN, Philip, RENDELL, Marc, RIDDLE, Matthew C, DOLE, Jo F, FREED, Martin I, ROSENSTOCK, Julio

“…A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes Philip Raskin , MD 1 , Marc Rendell , MD 2…”
Get full text

A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes by SUTTON, Martin St, RENDELL, Marc, DANDONA, Paresh, DOLE, Jo F, MURPHY, Karen, PATWARDHAN, Rita, PATEL, Jai, FREED, Martin

“…A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes Martin St. John…”
Get full text

Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes by Lebovitz, Harold E., Dole, Jo F., Patwardhan, Rita, Rappaport, Elizabeth B., Freed, Martin I.

“…This study evaluated the efficacy and safety of rosiglitazone monotherapy in patients with type 2 diabetes. After a 4-week placebo run-in period, 493 patients…”
Get full text

ASCEND Program: Efficacy and Safety from ASCEND-D and -ND and Overall MACE Finding: FR-OR66 by Singh, Ajay K., Carroll, Kevin, Perkovic, Vlado, Solomon, Scott D., Jha, Vivekanand, Johansen, Kirsten L., Lopes, Renato D., Macdougall, Iain C., Obrador, Gregorio T., Waikar, Sushrut S., Wanner, Christoph, Wheeler, David C., Wiecek, Andrzej, Blackorby, Allison, Cizman, Borut, Cobitz, Alexander R., Davies, Rich, Dimino, Tara L., Dole, Jo F., Kler, Lata, Meadowcroft, Amy M., Taft, Lin, Zhu, Xinyi, McMurray, John

Get full text

Rosiglitazone monotherapy is effective in patients with type 2 diabetes by LEBOVITZ, Harold E, DOLE, Jo F, PATWARDHAN, Rita, RAPPAPORT, Elizabeth B, FREED, Martin I

“…This study evaluated the efficacy and safety of rosiglitazone monotherapy in patients with type 2 diabetes. After a 4-week placebo run-in period, 493 patients…”
Get full text

Near-Normoglycemia, with Meaningful Discontinuations of Prandial Insulin, by Adding Weekly Albiglutide (Albi) to Uncontrolled Basal/Bolus Insulin-Treated Type 2 Diabetes (T2DM) by ROSENSTOCK, JULIO, NINO, ANTONIO J., SOFFER, JOSEPH, MALLORY, JASON M., ERSKINE, LOIS M., ACUSTA, ANDRE, DOLE, JO F., CARR, MOLLY, HOME, PHILIP

“…The glycemic efficacy of weekly Albi 50 mg to replace prandial insulin lispro (Lis) was evaluated in T2DM inadequately controlled on a multiple daily insulin…”
Get full text

Rosiglitazone Monotherapy Significantly Lowers HbA1c Levels in Treatment-Naive Type 2 Diabetic Patients by GRUNBERGER, GEORGE, DOLE, JO F, FREED, MARTIN I

Get full text

Rosiglitazone Improves Glycemic Control in Poorly Controlled, Insulin-Treated Type 2 Diabetes by RASKIN, PHILIP, DOLE, JO F, RAPPAPORT, ELIZABETH B

Get full text

Rosiglitazone Improves Blood Pressure in Patients with Type 2 Diabetes Mellitus by BAKRIS, GEORGE L, DOLE, JO F, PORTER, LISA E, HUANG, CHUN, FREED, MARTIN I

Get full text

Rosiglitazone Does Not Adversely Affect Cardiac Structure or Function in Patients with Type 2 Diabetes by SUTTON, MARTIN ST. JOHN, DOLE, JO F, RAPPAPORT, ELIZABETH B

Get full text